Oracle Stock: A High-Stakes Bet on AI Ambition

The investment community is deeply divided over Oracle Corporation, with analysts and short sellers presenting starkly contrasting visions for the technology giant’s future. Following a significant share price correction, the debate centers on whether the company represents a historic buying opportunity or a debt-laden risk.

Surging Short Interest Meets Bullish Price Targets

A new wave of skepticism has emerged from credit specialists and short sellers. Monachil Capital recently labeled Oracle shares as an inexpensive hedge against a potential bubble in artificial intelligence credit. The firm’s Chief Investment Officer, Ali Meli, pointed specifically to the company’s substantial debt load of approximately $108 billion as a primary concern.

This bearish argument focuses on financial stability. Critics warn that massive capital expenditures, which reached $20.5 billion, combined with high leverage, create significant risk should major clients like OpenAI face liquidity constraints. Unlike cash-rich competitors such as Microsoft or Google, Oracle is largely funding the “gigawatt-scale expansion” of its data centers through debt, potentially making its equity more vulnerable to credit market shifts.

Contrasting this view, analysts from Jefferies and Mizuho reaffirmed their Buy ratings on Monday, maintaining a bold price target of $400 per share. From a pre-market level near $196, this implies potential upside exceeding 100 percent.

Weighing Record Backlog Against Execution Risks

The company’s latest quarterly results, reported on December 10th, highlighted the current tension. While total revenue grew 14% to $16.1 billion, performance in the license business segment fell short of expectations.

Should investors sell immediately? Or is it worth buying Oracle?

The bulls base their optimism largely on Oracle’s remaining performance obligations (RPO), which have ballooned to a record $523 billion. Jefferies analysts argue that the stock, having fallen nearly 40% from its September peak, is now deeply undervalued. They note that the company trades at an enterprise value to estimated 2027 EBIT multiple of 16, presenting an attractive entry point. Their thesis suggests the firm’s aggressive expansion plans are justified by unrelenting demand for AI infrastructure.

For investors, the core challenge is balancing this enormous growth potential against clear balance sheet risks. The unprecedented order backlog indicates that market demand is not the issue; the critical question is whether Oracle can execute efficiently and allocate capital profitably without further straining its credit profile.

A Technical and Fundamental Inflection Point

From a chart perspective, the situation remains tense. Analysts note that for a sustained trend reversal to take hold, the shares must reclaim the psychologically important $200 level.

The upcoming third-quarter results in March will be a crucial test. They are expected to show whether Oracle can begin to convert its massive contract backlog into profitable revenue without additional pressure on its financial standing. The outcome will likely determine if the stock is poised for a dramatic recovery or faces further headwinds from concerned creditors and skeptics.